1. News | 2015.01.18

   Pasteur International Joint Research Units

   Institut Pasteur is launching an International Call for Proposals for the creation of Pasteur International Joint Research Units within the Institut Pasteur International Network (RIIP), and within host institutions outside the RIIP.   Who can apply? Researchers from Institut Pasteur in Paris, researchers from the Institut Pasteur International Network or,  from international research...

2. News | 2015.01.18

   Segmented filamentous bacteria, partners in intestinal immunity, finally cultured in vitro

   Despite the vital role of segmented filamentous bacteria in establishing gut immune homeostasis in vivo in mice, scientists, for the past 50 years, have been unable to reproduce this symbiosis in vitro to shed light on the cellular and molecular interactions involved. Now, scientists have successfully cultured and reproduced the complex life-cycle of these bacteria outside their host for the...

3. News | 2015.01.15

   The biological basis of good health

   In a biological sense, what does it mean to be “in good health”? This far-reaching question is the focus of the “Laboratoire d'Excellence” project Milieu Intérieur (“Environment Within”). The Milieu Intérieur cohort is the first French cohort of its kind, comprised of a thousand healthy donors. Studying this cohort will help define the parameters of a...

4. News | 2015.01.22

   Ebola: Study of the chains of transmission in Conakry

   Researchers at the Institut Pasteur of Dakar and the Institut Pasteur in Paris have reconstructed chains of transmission of Ebola virus in the capital city of Guinea, from February to August 2014. The data show the positive impact of control measures on the evolution of the epidemic but highlight the challenges of Ebola control in large urban centres.

5. News | 2015.01.26

   Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases

   For 10 years, Total and its corporate foundation working alongside the Institut Pasteur and its International Network in the fight against infectious diseases. A new sponsorship agreement, of EUR 6 million for three years, was signed on 26 January 2015. It will provide funding, for public health and research projects in resource limited countries in order to better understand the therapeutic and...

6. News | 2015.02.02

   Moderna and Institut Pasteur Sign Strategic Research Collaboration

   Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, today announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna.

7. News | 2015.03.01

   Themis Bioscience’s Chikungunya Vaccine Study Results Published

   Phase 1 trial of the vaccine candidate which was developed under an R&D collaboration between Themis Bioscience GmbH and the Institut Pasteur (Paris) shows good immunogenicity, safety and tolerability.

8. News | 2015.03.04

   The "dream" of every cell is to become two cells

   Arnaud Echard (head of the Membrane Traffic and Cell Division Lab) and his team are working to understand how a parent cell physically "cleaves" itself in two to create two distinct daughter cells. The researchers revealed that intercellular bridges split and in doing so release a structure called "midbody remnant" (MBR) into the extracellular environment. This discovery could...

9. News | 2015.03.05

   Guillermo Dighiero is appointed Ambassador of Uruguay in France

   Uruguayan medical Doctor and Doctor es Sciences specialysed in Human biology at the French University of Pierre et Marie Curie, Guillermo Dighiero was Top Degree Research Director at CNRS (National Center for Scientific Research) and head of the Department of Pathophysiology in the Institut Pasteur in Paris until 2004. He is member, of French National Academy of Medicine, French Academy of...

10. News | 2015.03.05

    Interactions between the nuclear pore and chromatin are critical for HIV-1 replication

    Little is understood about the molecular mechanisms that actually enable the HIV to integrate its genetic material into certain regions of the human genome. The scientists were able to find this link and determine the role played by the chromatin environment and nuclear pores in the replication of HIV-1.

Pages